Weekly Policy Update: Drug Review Board Legislation Passes State Senate
By: Colorado BioScience Association Date: 05/07/2021
Senate Bill 175 (Prescription Drug Affordability Review Board) passed the Colorado Senate today on a vote of 19-16. The bill would create a prescription drug review board in Colorado that is charged w...
Learn MoreWeekly Policy Update: Colorado Legislature Finalizes State Budget
By: Colorado BioScience Association Date: 04/30/2021
The Colorado legislature finalized the state budget today, which will now be sent to Governor Polis for his signature. In addition to funding day-to-day operations of the state government, the $34.6 b...
Learn MoreCPC Works to Propel Beyond Research, Engage Community Directly
By: Colorado BioScience Association Date: 04/26/2021
CPC is a non-profit, mission-driven Academic Research Organization (ARO) that supports all phases of clinical research. Their academically led team provides fullservice support, offering scientific ov...
Learn MoreColorado BioScience Association Appoints New Board Members
By: Colorado BioScience Association Date: 04/26/2021
Colorado BioScience Association (CBSA) today announced the appointment of seven new members to its board of directors, Jim Kasic, CEO of EndoShape and Chairman of Boulder IQ; Anil Mathai, Vice Preside...
Learn MoreColorado’s Life Sciences Ecosystem Achieves Record Q1 Fundraising
By: Colorado BioScience Association Date: 04/19/2021
Colorado BioScience Association (CBSA) today announced the state’s life sciences community raised an unprecedented $704 million in the first quarter of 2021. Capital from public, private, and federal...
Learn MoreCBSA Urges CMS to Implement MCIT Rule Without Delay
By: Colorado BioScience Association Date: 04/19/2021
In January, CMS finalized a new rule called Medicare Coverage of Innovative Technologies (MCIT). The rule provides immediate national Medicare coverage for FDA-designated breakthrough devices and diag...
Learn MoreWeekly Policy Update: Biden’s Spending Proposal Signals Key Healthcare Priorities
By: Colorado BioScience Association Date: 04/16/2021
Last week the White House unveiled a $1.5 trillion discretionary spending request for the coming fiscal year. The request, which is only part of the President’s full budget proposal, is a sharp depart...
Learn MoreYour Help Needed Now: Tell Colorado Legislators to Protect Life Sciences Innovation
By: Colorado BioScience Association Date: 04/09/2021
The Colorado state legislature is considering a bill that creates a state drug review board with the power to set payment rates for medicines in Colorado. The unelected board could set price limits wi...
Learn MoreWeekly Policy Update: CBSA Convenes Roundtable Discussion with Congressman Joe Neguse
By: Colorado BioScience Association Date: 04/09/2021
CBSA convened a virtual roundtable this week with Congressman Joe Neguse, who represents Colorado’s second Congressional district. It was a great opportunity for leaders in our ecosystem to highlight...
Learn MoreWeekly Policy Update: New Study Examines Impact of Federal Drug Pricing Proposal
By: Colorado BioScience Association Date: 04/02/2021
Last week, the Council of State Bioscience Associations released a new study that shows the impact of foreign reference pricing on patient access to lifesaving medicines and investment in new treatmen...
Learn More